Would you like to know how many people have visited this page? Or how reputable the author is? Simply
sign up for a Advocate premium membership and you'll automatically see this data on every article. Plus a lot more, too.
I have 42 fans: Become a Fan. You'll get emails whenever I post articles on OpEd News
Dr. Dean Baker is a macroeconomist and Co-Director of the Center for Economic and Policy Research in Washington, D.C. He previously worked as a senior economist at the Economic Policy Institute and an assistant professor at Bucknell University. He received his Ph.D in economics from the University of Michigan.
SHARE Monday, June 25, 2018 Trade: It's About Class, Not Country
If Chinese corporations use technology developed by Boeing, Microsoft, or other US giants, this is bad news for their stockholders, but it doesn't directly harm the rest of us. In fact, if the Chinese corporations can then produce the same products at a lower price and then export them to the United States, this would be a gain for non-stockholders. This is the classic argument for free trade.
SHARE Monday, June 18, 2018 The Tax Cut and the Pay Increase: Halfway There
Some companies did announce pay increases, or more typically one-time bonuses, following the tax cut, but the increases going to workers are a small fraction of the money being used to buy back stocks. Many tax cut critics had pointed to this imbalance as evidence that workers will not benefit to any substantial extent from the tax cut.
(2 comments) SHARE Tuesday, June 5, 2018 No You a**holes, Obama Did Not Do It Too
The news in the report often moves financial markets. If the president can share information about the report with his favored audience then Donald Trump's friends will make money at the expense of everyone else's retirement accounts. For this reason, past presidents have been very careful to keep their mouth shut about the report until after it is available to the general public.
(1 comments) SHARE Thursday, May 31, 2018 Donald Trump and ZTE: a Party of One
Donald Trump stunned political observers and many of his supporters with a tweet expressing concern about the jobs being lost in China due to the troubles facing ZTE, a Chinese electronics manufacturer. He told his Commerce Secretary, Wilber Ross, to see what he could do to help ZTE.
(1 comments) SHARE Tuesday, May 22, 2018 Donald Trump's Big Pharma First Agenda
After handing huge tax cuts to the country's richest people and taking away health care insurance for millions, Donald Trump took another giant step toward abandoning his populist agenda last week. Instead of having Medicare negotiate to bring drug prices down, Trump put out a plan that is focused on making foreign countries pay more for drugs.
(5 comments) SHARE Tuesday, May 15, 2018 Krugman on Drugs
it is pretty crazy that we expect people when they are sick or dying to pay for research that has already been done. In almost all cases, the cost of manufacturing and delivering drugs is cheap, we make it expensive with government-granted patent monopolies. If we asked questions about paying for possibly life-saving drugs at their actual production costs, it would almost always be a no-brainer.
(1 comments) SHARE Tuesday, May 8, 2018 Helping Blue States Preserve the SALT: We Know the Beneficiaries Are Higher Income People
If we want to see headway on quality affordable child care, free college, expanded health care coverage, it will come from states like New York and California. The Republicans quite explicitly wanted to make it more difficult for states to be able to pursue progressive policies, which is why they limited the SALT deduction. So no, I have no problems trying to reverse this cheap trick.
SHARE Sunday, May 6, 2018 Yes Kids, You Can Have a Promising Career Scaring People About the Debt: Just Ask George Will
The vast majority of this debt is fixed rate mortgage debt. This debt is not going to be affected by a rise in interest rates. Car loans are also a large part of the debt. The vast majority of these loans are also fixed rate. Student debt and credit cards are the other major components. Much of the former is also fixed rate.
SHARE Tuesday, May 1, 2018 Making Finance Pay
It would be ideal if we could count on government agencies to regulate industry rather than be ripped-off by it, but that is clearly not the way business is done in Donald Trump's America. In this case, we can hope for more efficient public alternatives, which will take away the customers from Mulvaney's campaign contributors.
(1 comments) SHARE Friday, April 27, 2018 Dems' Job Guarantee Isn't Nearly as Easy as It Sounds
None of this means we should reject a job guarantee out of hand. We can start with a lower wage and limit the program to long-term unemployed, or in other ways restrict the size. But we should also look to measures to weaken the economic power of those at the top.
SHARE Tuesday, April 24, 2018 The Irresponsibility of Fiscal Responsibility
Economic policy will continue to suffer as long as the loudest voices in the debate have no understanding of how the economy works. Deficits can undoubtedly be harmful. When the economy is reaching its limits, as indicated by a shortage of workers or other inputs and rapidly rising wages and prices, a higher deficit will make this problem worse.
SHARE Sunday, April 22, 2018 Message to NYT Times: Growth in Our Trading Partners Is Good for the United States
Politicians like to call their deals "free trade" agreements because intellectual-types then think they have to support them. In reality, this pact includes the imposition of a number of regulatory measures that have nothing directly to do with free trade and enhanced patent, copyright, and related protections, which are explicitly protectionist.
(1 comments) SHARE Tuesday, April 10, 2018 New York State's Big Middle Finger to the Republican Tax Plan
It is likely that the employer-side payroll tax device will catch on quickly, even though it is not mandatory. It would be great if other liberal states adopted similar workarounds to preserve most of the SALT deduction for their residents. We would get a situation where the only people who lose the benefit of the SALT deduction would be higher-income people living in Republican states.
(1 comments) SHARE Monday, April 9, 2018 NYT News Section Goes Into Battle Against Trump Trade Wars: Warns of Higher Prices for Hip Replacements
Unfortunately, most politicians are staunchly protectionist when it comes to measures that might reduce the income of doctors, hospitals, and medical equipment manufacturers. They only are interested in reducing trade barriers when most of the losers are less-educated and less politically powerful workers.
SHARE Friday, April 6, 2018 Disagreeing With Krugman: Is China Stealing Knowledge?
These rules were about forcing developing countries to pay more money to companies like Pfizer and Microsoft for everything from drugs and medical equipment to seeds and software. It shouldn't be surprising that developing countries like China might not like these rules.
(3 comments) SHARE Monday, April 2, 2018 Why Should the Poor Pay High Drug Prices?
We have seen a lot of hyperventilating in political circles over Donald Trump's recently proposed tariffs on steel and aluminum. While these do not seem like well-considered policies, and are likely to do more harm than good even from the narrow standpoint of increasing manufacturing employment, they are not by themselves the horror story being presented.
SHARE Sunday, April 1, 2018 Roger Lowenstein, F**k Your Stock Portfolio
Congress should pass fiscal stimulus and the Fed should lower interest rates to sustain demand. The destruction of the counterfeiters' money should allow us to have demand in areas that meet the needs of the rest of us rather than the counterfeiters.
(1 comments) SHARE Friday, March 30, 2018 Will Interest Payments Take Up the Entire Federal Budget?
The deficit hawks hyperventilate endlessly about the former route of paying for things, but completely ignore the latter, even though it poses a much larger burden. In the case of prescription drugs alone the burden is more than $370 billion a year (we pay more than $450 billion for drugs that would likely cost less than $80 billion in a free market).
(3 comments) SHARE Wednesday, March 28, 2018 High CEO Pay: It's What Friends Are For
The explosion in the pay of corporate CEOs is well documented. While the heads of major corporations were always well paid, we saw their pay go from 20- to 30-times the pay of ordinary workers in the 1960s and 1970s to 200- or 300-times the pay of ordinary workers in recent years. Paychecks of more than $20 million a year are now standard.
SHARE Thursday, March 22, 2018 CON: Kudlow's fossilized beliefs could lead Trump further astray
Kudlow is an ideologue. This could be a serious problem with a president who often shoots from the hip without seriously considering the ramifications of his policies. Rather than trying to get Trump to consider various perspectives, Kudlow may just reinforce Trump in his ill-considered plans.